Apr 7, 2026

LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market

BOULDER, CO — April 07, 2026 — LBB Specialties (LBBS), a North American distributor of specialty chemicals and ingredients providing technical solutions with a customer-first approach, today announced a new partnership with DMC Biotechnologies (DMC), a U.S.-based ingredient supplier pioneering sustainable fermentation technologies. Through this agreement, LBB Specialties will serve as the distributor of DMC’s KeyPura™ fermented myo-inositol and D-chiro-inositol in the United States and Canada — two next-generation ingredients produced through precision fermentation — serving the Human Nutrition, Food, Personal Care, and Life Science markets.

“This collaboration brings to market a cleaner, more sustainable, and more reliable source of inositols. As essential compounds, inositols play critical roles in hormonal balance, reproductive health, infant brain development, blood sugar regulation with improved insulin sensitivity, and overall metabolic health” said Jerry Whelan, Senior Vice President, Food & Nutrition at LBBS. “DMC leverages their proprietary precision fermentation technology to produce bio-identical ingredients without solvents, with greater purity and consistency, and with a significantly lower environmental footprint than traditional chemical production methods”.

“Together, LBBS and DMC are shaping the future of ingredient innovation,” said Rusty Pittman, Vice President of Business Development at DMC. “This partnership underscores our shared commitment to high-purity, naturally derived ingredients with proven health benefits – responsibly sourced and sustainably produced. The partnership further strengthens LBBS’s growing portfolio of functional and sustainable ingredient technologies that empower brands to meet the next generation of consumer expectations, without compromising performance, purity, or planet.

For more information about DMC’s KeyPura™ fermented inositols, please contact LBB Specialties today.

About LBB Specialties
LBB Specialties is a dedicated provider of specialty chemicals and ingredients, specializing in sales, marketing, and distribution across North America. We provide technical solutions with a customer-first approach, serving diverse end-markets through five industry and market business units: Care, Food & Nutrition, Industrial Specialties, Life Sciences, and Canada. www.LBBSpecialties.com

Media Contact:
Ahmed Hanafy
[email protected]

About DMC
DMC is a U.S.-based biomanufacturer redefining how the world produces chemicals. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance ingredient quality, and strengthen global supply chain resilience. The company’s proprietary platform, Dynamic Metabolic Control™, simplifies biological processes to enable predictable, scalable, and highly efficient fermentation—unlocking a new era of low-impact chemical manufacturing.

Media Contact:
[email protected]

 

 

Other NEWS

DMC Biotechnologies, Inc. Announces First Close of $1.75M Equity Financing Led by Leuven (Belgium) based Capricorn Venture Partners

DMC & Duke Receive NSF STTR Phase 1 Award

STTR Phase I: Commercialization of Synthetic Metabolic Valves Award Information Agency: National Science Foundation Branch: N/A Contract: 1549624 Agency Tracking Number: 1549624 Amount: $225,000.00 Phase: Phase I Program: STTR Solicitation Topic Code: BT Solicitation...

read more
DMC Biotechnologies, Inc. Announces First Close of $1.75M Equity Financing Led by Leuven (Belgium) based Capricorn Venture Partners

DMC & Duke Receive NSF STTR Phase 1B Award

Award Abstract #1549624 STTR Phase I: Commercialization of Synthetic Metabolic Valves NSF Org: IIP Div Of Industrial Innovation & Partnersh Initial Amendment Date: December 18, 2015 Latest Amendment Date: December 23, 2016 Award Number: 1549624 Award Instrument:...

read more
DMC Biotechnologies, Inc. Announces First Close of $1.75M Equity Financing Led by Leuven (Belgium) based Capricorn Venture Partners

Duke and DMC Receive DOE Award for Innovative Bioenergy R&D

DOE Announces $10 Million for Innovative Bioenergy Research and Development The U.S. Department of Energy announced up to $10 million in funding for six projects representing innovative technologies and solutions to advance bioenergy development. These projects,...

read more